Replacing cholesterol and PEGylated lipids with zwitterionic ionizable lipids in LNPs for spleen-specific mRNA translation
Science Advances · 10.10.2025 · 11 (41)
DOI: 10.1126/sciadv.ady6460 ↗Kurz gefasst
Fachartikel in der Zeitschrift Science Advances, erschienen am 10.10.2025. Verfasst von Yu Zhao und 17 weiteren Autor:innen. Beteiligte Einrichtung: Meinig School of Biomedical Engineering, Cornell University, Ithaca, NY 14853, USA. Hauptthemen laut MEDLINE: Spleen, Polyethylene Glycols, Cholesterol, RNA, Messenger. Die Arbeit wurde bisher 41-mal zitiert (Crossref) und nennt 52 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NIAID NIH HHS.
Abstract (Originalsprache)
The spleen is emerging as a key vaccination target. However, existing lipid nanoparticles (LNPs) primarily accumulate in the liver, limiting their efficacy in vaccine therapy. The cholesterol in current LNP formulations promotes their uptake by hepatocytes, while the polyethylene glycol-modified (PEGylated) lipids induce PEG immunogenicity, further reducing the efficacy in the setting of repeated administrations. We develop a three-component (ThrCo) LNP by replacing cholesterol and PEGylated lipids in Pfizer-BioNTech LNPs with zwitterionic pyridine carboxybetaine (PyCB) ionizable lipids (ILs), achieving ~70% lower liver accumulation and a 4.5-fold increase in spleen-specific mRNA translation. PyCB ILs enhance LNP hydrophilicity, stabilizing the outer membrane to compensate for cholesterol removal. PyCB groups also exhibit strong protonation at endosomal pH, facilitating mRNA translation. The zwitterionic surface of ThrCo LNP reduces protein adsorption, thereby preventing the accelerated blood clearance effect caused by PEGylated lipids following repeated administrations. Thus, ThrCo LNP–based vaccines efficiently deliver mRNA to splenic antigen-presenting cells, boosting immune responses and improving therapeutic outcomes.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Meinig School of Biomedical Engineering, Cornell University, Ithaca, NY 14853, USA.
- Department of Biological and Environmental Engineering, Cornell University, Ithaca, NY 14853, USA.
- Department of Materials Science and Engineering, Cornell University, Ithaca, NY 14853, USA.
- Smith School of Chemical and Biomolecular Engineering, Cornell University, Ithaca, NY 14853, USA.
- Department of Molecular Biology and Genetics, Cornell University, Ithaca, NY 14853, USA.
- Department of Biological and Biomedical Sciences, Cornell University, Ithaca, NY 14853, USA.
ORCID-Profile: Yu Zhao, Zhen Tian, Jialiang Wang, Zeyu Cao, Pingchuan Liu, Simian Cai, Erica Wagner, Amy Laflin, Wenchao Gu, Yanru Cui, Shaoyi Jiang
Förderung
- NIAID NIH HHS
Zitieren
APA
Zhao, Y., Tian, Z., Wang, J., Cui, M., Cao, Z., Liu, P., Li, R., Cai, S., Hu, Y., Ma, Y., Wagner, E., Laflin, A., Gu, W., Cui, Y., Tang, C., Fountain, H., Wang, R., & Jiang, S. (2025). Replacing cholesterol and PEGylated lipids with zwitterionic ionizable lipids in LNPs for spleen-specific mRNA translation. Science Advances, 11(41). https://doi.org/10.1126/sciadv.ady6460
Vancouver
Zhao Y, Tian Z, Wang J, Cui M, Cao Z, Liu P, et al. Replacing cholesterol and PEGylated lipids with zwitterionic ionizable lipids in LNPs for spleen-specific mRNA translation. Science Advances. 2025;11(41). doi:10.1126/sciadv.ady6460
BibTeX
@article{Zhao2025,
author = {Zhao, Yu and Tian, Zhen and Wang, Jialiang and Cui, Meng and Cao, Zeyu and Liu, Pingchuan and Li, Ruoxin and Cai, Simian and Hu, Yuping and Ma, Yufei and Wagner, Erica and Laflin, Amy and Gu, Wenchao and Cui, Yanru and Tang, Chenjue and Fountain, Herbert and Wang, Ruixuan and Jiang, Shaoyi},
title = {Replacing cholesterol and PEGylated lipids with zwitterionic ionizable lipids in LNPs for spleen-specific mRNA translation},
journal = {Science Advances},
year = {2025},
volume = {11},
number = {41},
doi = {10.1126/sciadv.ady6460}
}
EUVIMED